This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
standard medical management. Referred patients were then reviewed by TLG or associated physicians and, before randomisation, medical treatment was optimised for individual participants. If necessary, referrals were made for smoking cessation counselling, dietetic, occupational therapy, or physiotherapy assessment usually available at the hospital. If any changes were made to management, entry into the study was deferred for 2 months after the last change. Even though each programme was designed to accommodate up to 20 patients, recruitment was slow during the early stages of the research phase and programmes commenced with 18 to 20 patients. During the study period, 99 patients were included in the outpatient rehabilitation group and 101 in the usual care group. The authors did not report the baseline characteristics of the patients in both groups.
Study design
The study was a randomised controlled trial. It was unclear how many centres were involved in this study. Randomisation was carried out in a random fashion, and further details of the randomisation and allocation procedures were reported elsewhere (Griffiths et al, see Other Publications of Related Interest). The groups were followed up for one year. Sixteen to 17 patients completed each programme, but the overall loss to follow-up during the total study period was not reported.
Analysis of effectiveness
The analysis was conducted on an intention to treat basis. The outcomes used were: quality of life, as measured using the medical outcomes survey Short Form 36 item questionnaire (SF-36) before randomisation, at the end of the 6-week intervention period, and 12 months after entering the study; and the death rate during the 1-year follow-up period.
It is not possible to say whether the groups were shown to be comparable at analysis, as the authors did not provide the baseline characteristics of the patients in both groups. It is probable that these were reported elsewhere (Griffiths et al., see Other Publications of Related Interest).
Effectiveness results
The SF-36 scores were reported elsewhere (Griffiths et al., see Other Publications of Related Interest).
The derived SF-6D utility scores for the control group were 0.34 (+/-0.08) before the intervention, 0.37 (+/-0.09) at 6 weeks after entering the study, and 0.4 (+/-0.09) at 12 months after entering the study.
The corresponding scores for the outpatient rehabilitation group were 0.33 (+/-0.08) (before intervention), 0.43 (+/-0.10) (6 weeks) and 0.4 (+/-0.11) (12 months), respectively.
Six of the 99 patients in the rehabilitation group and 12 of the 101 patients in the control group died during the study.
Clinical conclusions
Patients in the rehabilitation group had a lower mortality rate than those in the control group. They also had higher utility scores 6 weeks after entering the study.
Measure of benefits used in the economic analysis
The measure of health benefits used was the quality-adjusted life-years (QALYs). The SF-36 scores measuring health status on eight different scales were converted to a single "preference based" utility score, which indicated the value that would be given to their health state by the general population. This was achieved by extracting the appropriate SF-36 responses and using them to complete a 6-item health state classification, the SF-6D. The SF-6D utility score was combined with survival data to produce QALYs.
Direct costs
The resource quantities and the costs were not reported separately in this study, although resource use and differences in resource use between the two groups were reported by Griffiths et al. (see Other Publications of Related Interest). The direct costs included in the analysis were those of the primary and secondary care health services and those of the patient. Data relating to the costs to the health service of providing the rehabilitation programme were gathered from the staff involved in managing the service provision, and staff from the finance department of the NHS trust. All direct costs were allocated to an individual 6-week programme and it was assumed that there was no difference in the costs of delivering each 6-week period. The transport cost was based on the estimate of cost provided by the local ambulance trust. At the end of the 1-month follow-up study, proformas were circulated to the patients' general practitioners. These recorded the number of consultations at the surgery, the number of home visits, and the number of contacts with other primary care staff. The information systems of the base hospital and six other district hospitals were interrogated for patient admissions.
Patient costs incurred in attending the programme were collected from a questionnaire distributed to the patients. Given that only a few patients indicated a cost, a proxy for patient costs was based on the average mileage. Discounting was not relevant since the costs were incurred during one year and, hence, was not performed. The study reported the average costs. The price year was not reported.
Statistical analysis of costs
Due to the incremental cost-utility ratio having an unknown distribution, and the necessity to estimate the sampling distribution around the point estimate non-parametrically, 1,000 further hypothetical incremental costs and utilities were modelled using bootstrap techniques. Significance appears to have been set at a p-value of less than 0.05.
Indirect Costs
No indirect costs were included in the analysis.
Currency

UK pounds sterling ().
Sensitivity analysis
No sensitivity analysis was performed.
Estimated benefits used in the economic analysis
Significantly more QALYs were generated in the rehabilitation group (0.381 +/-0.01) than in the control group (0.351 +/-0.08), (p=0.03).
Cost results
The cost to the National Health Service of providing each rehabilitation programme was 12,120.
The mean cost per patient was 1,674 (+/-1,588) in the rehabilitation group versus 1,826 (+/-3,295) in the control group (p=0.68).
Synthesis of costs and benefits
The costs and benefits were combined by calculating an incremental cost-utility ratio (i.e. the additional cost required per QALY gained). The results from the bootstrap exercise indicated that the probability of the true incremental costutility ratio of the programme being below 0 per QALY was 0.64. The probability that the true cost per QALY was below 3,000, 10,000 and 17,000 were, respectively, 0.74, 0.90 and 0.95.
